You are Trying to View a Free ArticleDaily News You Can't Find Anywhere Else
Biosimilars Still Not Drug of Choice in U.S., an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 225 Words
The biosimilar (the copycat version of a prescription drug, but not an identical duplicate) market share continues to grow.
Subscribe Now! All Fields Required...
- Join Johns Manville Industrial Masters Course
- Global Fill Finish Market Continues to Soar, an Industrial Info Market Brie...
- Botox King Allergan Injects $72 Million into Irish Operation
- Bayer, adivo, to Collaborate on Veterinary Medicines, an Industrial Info Ma...
- Novartis Completes Spinoff of Alcon Eye Care Business
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker